Search hospitals > Quebec > MONTREAL
Novartis Investigative Site
Claim this profileMONTREAL, Quebec H3T 1E2
Global Leader in Breast Cancer
Global Leader in Leukemia
Conducts research for Multiple Sclerosis
Conducts research for Cancer
Conducts research for Myeloid Leukemia
289 reported clinical trials
0 medical researchers
Summary
Novartis Investigative Site is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Leukemia, Multiple Sclerosis, Cancer, Myeloid Leukemia and other specialties. Novartis Investigative Site is involved with conducting 289 clinical trials across 283 conditions. There are 0 research doctors associated with this hospital, such as .Area of expertise
1Breast Cancer
Global LeaderStage IV
Stage III
HER2 positive
2Leukemia
Global LeaderBCR-ABL1 positive
BCR-ABL positive
CD19 positive
Top PIs
Clinical Trials running at Novartis Investigative Site
Multiple Sclerosis
Lung Cancer
Chronic Urticaria
Coronary Heart Disease
Spinal Muscular Atrophy
Coronary Artery Disease
Giant Cell Arteritis
Acute Kidney Injury
Oligodendroglioma
Neurofibromatosis
Ofatumumab
for Multiple Sclerosis
The purpose of this study is to collect long-term safety, tolerability, effectiveness and health outcomes data in eligible subjects who have participated in a Novartis ofatumumab clinical MS study. Vaccination sub-study The purpose of this research sub-study is to find out the effects of ofatumumab on the development of antibody responses to selected vaccines and keyhole limpet hemocyanin (KLH) neo-antigen in subjects with relapsing multiple sclerosis (RMS).
Recruiting2 awards Phase 3
Remibrutinib vs Teriflunomide
for Multiple Sclerosis
This trial compares two medications, remibrutinib and teriflunomide, for treating patients with relapsing multiple sclerosis. These patients have repeated episodes of symptoms and need effective treatments. The medications work by controlling the immune system to prevent it from causing damage to the nervous system. Teriflunomide is an approved medication for adults with relapsing multiple sclerosis.
Recruiting2 awards Phase 3
Ofatumumab + Siponimod vs Fingolimod
for Pediatric Multiple Sclerosis
This trial tests three medications in children and teens with multiple sclerosis to find effective treatments. The drugs work by reducing harmful immune cells or preventing them from attacking the nervous system.
Recruiting1 award Phase 3
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Novartis Investigative Site?
Novartis Investigative Site is a medical facility located in MONTREAL, Quebec. This center is recognized for care of Breast Cancer, Leukemia, Multiple Sclerosis, Cancer, Myeloid Leukemia and other specialties. Novartis Investigative Site is involved with conducting 289 clinical trials across 283 conditions. There are 0 research doctors associated with this hospital, such as .